Cancer Biology & Medicine

 


Cancer Biology & Medicine

Cancer Biology & Medicine is a peer-reviewed open-access journal published by the Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. Published quarterly, the journal provides innovative and significant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics:

● Cancer genetics

● Cancer and stem cell biology

● Molecular and clinical immunology

● Cancer prevention and epidemiology

● Cancer biomarkers

● Radiation oncology

● Oncology clinical trials

● Mechanisms of drug sensitivity and resistance

● Targeted therapy and immunotherapy

● Multidisciplinary treatment and personalized medicine

Author Benefits

● Easy submission via online system

● Efficient and professional peer review

● Rapid pre-print online publication

● No charge for publication and open access

● International visibility-All full texts are free in PubMed Central

 

Announcements

 

Publication of the 3rd issue in 2017

 

The 3rd issue of 2017 has been published on August 15th. The contents include Chinese expert consensus and guidelines on papillary thyroid microcarcinoma, applications of nanotechnology in cancer treatment, small RNAs and NF-κB related mechanism for cancer therapy, the use of specific molecular imaging in HER2-positive breast cancer, vitamin D receptor polymorphisms and cutaneous malignant melanoma, a single center experience on rectal adenocarcinoma, and so on. We hope that these articles will be helpful to your research and clinical practice. We also warmly welcome you to submit your studies to Cancer Biology & Medicine.

Please browse the August issue by clicking here.

 
Posted: 2017-08-15
 

Publication of the 2nd issue in 2017

 

The latest issue of Cancer Biology & Medicine has been published on May 15th. It highlighted pathways referring to cancer metastasis and tumor microenvironment, oncologic immunology, novel strategy for detection of Lynch syndrome, biologic prognostic model of diffuse large B-cell lymphoma, vitamin D receptor expression in cutaneous melanoma, chemoradiotherapy-associated oral lesions in oral squamouscell carcinoma, and so on. We hope the articles in this issue will benefit your research and clinical practice. Click here to read fulltexts.

 
Posted: 2017-05-15
 
More Announcements...

Vol 14, No 3: August 2017

Table of Contents

Guideline

2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma PDF
Ming Gao, Minghua Ge, Qinghai Ji, Ruochuan Cheng, Hankui Lu, Haixia Guan, Li Gao, Zhuming Guo, Tao Huang, Xiaoming Huang, Xiaoming Li, Yansong Lin, Qinjiang Liu, Xin Ni, Yi Pan, Jianwu Qin, Zhongyan Shan, Hui Sun, Xudong Wang, Zhengang Xu, Yang Yu, Daiwei Zhao, Naisong Zhang, Sheng Zhang, Ying Zheng, Jingqiang Zhu, Dapeng Li, Xiangqian Zheng, Chinese Association of Thyroid Oncology (CATO), Chinese Anti-Cancer Association 203-211

Review

Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer PDF
Meng Zhang, Ergang Liu, Yanna Cui, Yongzhuo Huang 212-227
Recent progress on nanoparticle-based drug delivery systems for cancer therapy PDF
Yanru Xin, Mingming Yin, Liyuan Zhao, Fanling Meng, Liang Luo 228-241
Natural and artificial small RNAs: a promising avenue of nucleic acid therapeutics for cancer PDF
Sunny Yadav, Mamta Shekhawat, Devashree Jahagirdar, Nilesh Kumar Sharma 242-253
Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode PDF
Spiros A. Vlahopoulos 254-270
Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer PDF
Wei Chen, Xiaofeng Li, Lei Zhu, Jianjing Liu, Wengui Xu, Ping Wang 271-280
Survival after pulmonary metastasectomy in colorectal cancer patients: does a history of resected liver metastases worsen the prognosis? A literature review PDF
Jon Zabaleta, Borja Aguinagalde, Iker Lopez, Arantza Fernandez-Monge, Jose M. Izquierdo, Jose I. Emparanza 281-286

Original Article

BRAF mutation in colorectal carcinomas with signet ring cell component PDF
Serap Yalcin, Onder Onguru 287-292
Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation PDF
Avgi Tsolou, Maria Liousia, Dimitra Kalamida, Stamatia Pouliliou, Alexandra Giatromanolaki, Michael Koukourakis 293-301
BsmI (rs1544410) and FokI (rs2228570) vitamin D receptor polymorphisms, smoking, and body mass index as risk factors of cutaneous malignant melanoma in northeast Italy PDF
Sabina Cauci, Vincenzo Maione, Cinzia Buligan, Martina Linussio, Diego Serraino, Giuseppe Stinco 302-318
Expression levels of β-catenin and galectin-3 in meningioma and their effect on brain invasion and recurrence: a tissue microarray study PDF
Rehab Allah Ahmed, Abdelhadi M Shebl, Hany Onsy Habashy 319-326
Potential predictive factors for pathologic complete response after the neoadjuvant treatment of rectal adenocarcinoma: a single center experience PDF
Feryel Letaief, Meher Nasri, Mouna Ayadi, Khedija Meddeb, Amina Mokrani, Yosra Yahyaoui, Nesrine Chraiet, Henda Raies, Amel Mezlini 327-334


OUR FRIENDS